Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase Ib Trial of Metformin, Digoxin, Simvastatin in Patients With Advanced Pancreatic Cancer and Other Advanced Solid Tumors

Summary

The purpose of this phase Ib trial is to evaluate the safety and tolerability of metformin, digoxin and simvastatin in patients with pancreatic cancer and other advanced solid tumors.

General Information

NCT#: NCT03889795
Study ID: C3
Trial Phase: Phase I

Trial Sponsor: University of Toledo
Therapies Used in This Trial: C3 (Metformin, Digoxin, Simvastatin)

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search